// App-Quantinova.ai

: Use of Rituximab in the treatment of CTD-ILD in RA patients

Researchers

Presenter

  • Francesco Bini

Principal Investigators

  • Dina Visca

  • Angelo De Lauretis

  • Bruno Bodini

  • Daniele Colombo

  • Paola Faverio

  • Adriano Vaghi

Medical Centers

  • Ass-rhodense, Milano (Mi, Italy

  • IRCCS Maugeri, Tradate, Italy

  • UniMib, Monza, Italy

  • Asst-Rhodense, Monza, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Idiopathic pulmonary fibrosis

  • Interstitial lung disease

  • Rheumatoid arthritis

  • Pulmonary fibrosis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved